Table 2.
The prevalence of comorbidities associated with COVID-19 reinfections, with confirmed clinical admissions and self-reported data.
| Comorbidities or Immunodeficiencies | No. (%) | |
|---|---|---|
| x1 Reinfected Individuals | x2 Reinfected Individuals | |
| Diabetes | 191 (19.2) | 6 (17.1) |
| Hypertension | 177 (17.8) | 9 (25.7) |
| Obesity | 159 (16) | 7 (20) |
| Respiratory Diseases | 127 (12.8) | 5 (14.2) |
| Cardiovascular Diseases | 116 (11.7) | 2 (5.7) |
| Cancer | 54 (5.4) | 0 |
| HIV Infection | 43 (4.3) | 0 |
| Pregnancy | 42 (4.2) | 1 (2.9) |
| Immunosuppressive Drugs | 24 (2.4) | 1(2.9) |
| Chronic Kidney Disease | 24 (2.4) | 2 (5.7) |
| Sickle Cell Anemia | 22 (2.2) | 1 (2.9) |
| History of Stroke | 8 (0.8) | 0 |
| Organ Transplant | 7 (0.7) | 1 (2.9) |
| Total | 994 | 35 |
HIV, Human Immunodeficiency Virus.
Data are No. (%).